Avantor AVTR recently entered into a strategic partnership with BlueWhale Bio to accelerate innovation in CAR-T cell therapy ...
The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. | The stars have aligned for Bristol Myers Squibb ...
Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell ...
While the benefits of AI are clear, the amount data sets needed for effective AI integration is proving to be a challenge.
Researchers at the First Affiliated Hospital of the University of Science and Technology of China claim that an in vivo CD8 T ...
SAN JOSE, Calif., Aug. 12, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...